Linezolid, Chloramphenicol & Other Reserve Drugs
When the resistant Gram-positive bugs — MRSA, VRE — have defeated the usual drugs, a few reserve antibiotics remain. But each carries a warning sign: one can quietly stack a psychiatric drug into a serotonin crisis, another was once a wonder drug until it started killing newborns and destroying bone marrow. These are the ribosome-blockers of last resort, and their toxicities are as memorable as their power.
A patient being treated for depression with an antidepressant develops a serious resistant infection, and is started on linezolid — a powerful reserve antibiotic for MRSA and VRE. Within a day he becomes agitated, feverish, his muscles twitching and reflexes overactive: serotonin syndrome. The link is hidden in the antibiotic's chemistry: linezolid is a mild monoamine oxidase inhibitor, so combined with a serotonergic drug it can push serotonin dangerously high. This is exactly the serotonin syndrome from the psychiatry chapter — arriving, unexpectedly, from an antibiotic.
Linezolid: the oral drug for resistant Gram-positives
Linezolid binds the 50S ribosome at a unique early site. Linezolid (an oxazolidinone) binds the 50S ribosome at a spot no other antibiotic uses, blocking protein synthesis right at the start — which means there's little cross-resistance with other ribosome drugs. It covers the difficult Gram-positive organisms, including MRSA and vancomycin-resistant enterococci (VRE), and — unusually for a drug this powerful — it's fully absorbed by mouth, so patients can often switch from IV to oral tablets. Its toxicities set the limits. Used beyond about two weeks it can suppress the bone marrow (dropping platelets and other blood cells) and, over longer courses, cause nerve damage to the limbs and eyes. And because it weakly inhibits MAO, it risks serotonin syndrome with antidepressants and a tyramine reaction with certain foods — the same interactions you learned with the MAO inhibitors. A precious drug, reserved and time-limited.
Chloramphenicol: a cautionary classic
Chloramphenicol also binds the 50S ribosome and is broad and cheap — yet in wealthy countries it's almost abandoned, kept for a few desperate situations, because of two frightening toxicities. It can cause aplastic anaemia: a rare, unpredictable, and often fatal collapse of the bone marrow that can strike even from a small dose. And in newborns it causes 'grey baby syndrome' — because a neonate's liver can't yet glucuronidate the drug to clear it (straight from the metabolism chapter), it accumulates to toxic levels, turning the baby ashen and gravely ill. Where safer alternatives exist, chloramphenicol is avoided; but in some low-resource settings and specific infections (like certain cases of typhoid or eye drops), it still has a role. A once-great drug, now a lesson in why toxicity ended a career.
- Linezolid binds 50S at a unique site; covers MRSA & VRE; fully oral bioavailability.
- Linezolid toxicities: myelosuppression (>2 weeks), neuropathy (long use), serotonin syndrome (weak MAOI).
- Chloramphenicol binds 50S, broad — but risks aplastic anaemia and grey baby syndrome.
- Grey baby syndrome = neonatal inability to glucuronidate the drug → toxic accumulation.
- These are reserve drugs for resistant infections, used with monitoring and caution.
Two threads from earlier chapters converge here. Linezolid's serotonin-syndrome risk is the psychiatry lesson reappearing — an antibiotic that is secretly a mild MAO inhibitor, so it must not be casually combined with SSRIs or other serotonergic drugs. And chloramphenicol's grey baby syndrome is the metabolism lesson made lethal — a newborn's immature glucuronidation can't clear the drug, so it piles up to toxicity. Recognizing these patterns from across the whole course is exactly what lets you predict a drug's danger before it happens.
- Combining linezolid with an SSRI/MAOI without care — serotonin syndrome (it's a weak MAOI).
- Using linezolid long-term without monitoring blood counts — myelosuppression.
- Giving chloramphenicol to a neonate — grey baby syndrome from impaired glucuronidation.
- Forgetting chloramphenicol can cause fatal aplastic anaemia even at low doses.
Why must linezolid be used cautiously with antidepressants?
- Linezolid binds 50S uniquely, covers MRSA/VRE, is fully oral — reserve drug.
- Watch myelosuppression, neuropathy, and serotonin syndrome (weak MAOI).
- Chloramphenicol (50S, broad) risks aplastic anaemia and grey baby syndrome.
- Both are reserve drugs — recognize their signature toxicities before prescribing.
- Katzung BG. Basic & Clinical Pharmacology — Oxazolidinones, Chloramphenicol & Streptogramins.
- Brunton LL, et al. Goodman & Gilman's The Pharmacological Basis of Therapeutics — Protein synthesis inhibitors (linezolid, chloramphenicol).
- Rang HP, Dale MM, et al. Rang & Dale's Pharmacology — Miscellaneous protein-synthesis inhibitors.
- IDSA guidelines — MRSA & VRE treatment (linezolid).
- Whalen K. Lippincott Illustrated Reviews: Pharmacology — Linezolid & chloramphenicol.
